Tahir Nayha, Koorapati Gowthami, Prasad Sonika, Jeelani Hafiz Muhammad, Sherchan Robin, Shrestha Jishna, Shayuk Maryna
Internal Medicine, Chicago Medical School, Internal Medicine Residency Program, Northwestern Medicine McHenry Hospital, McHenry, USA.
Cureus. 2021 Jul 25;13(7):e16624. doi: 10.7759/cureus.16624. eCollection 2021 Jul.
While mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. We report a case of transverse myelitis and Bell's palsy after receiving Johnson and Johnson COVID-19 vaccination under the emergency use authorization in a healthy young woman with no past medical history. Other possible etiologies of her symptoms were ruled out, and she was treated successfully with steroids and plasma exchange.
在全球范围内开展针对2019冠状病毒病(COVID-19)的大规模免疫接种之际,需要迅速评估的安全问题和不良事件也不断出现。我们报告了一例在紧急使用授权下接种强生公司COVID-19疫苗后发生横贯性脊髓炎和贝尔麻痹的病例,患者为一名既往无病史的健康年轻女性。其症状的其他可能病因已被排除,她接受了类固醇和血浆置换治疗并成功康复。